Covalent interactions of reactive naphthalene metabolites with proteins

M. Cho, C. Chichester, D. Morin, Charles Plopper, Alan R Buckpitt

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Naphthalene produces selective necrosis of Clara cells in the mouse but not in the rat. The pulmonary toxicity depends on cytochrome P450-mediated metabolism; however, the selective pulmonary toxicity of naphthalene in the mouse does not correspond to tissue-selective covalent binding of reactive naphthalene metabolites in vivo. These studies compare reactive metabolite binding in target and nontarget cells and in various subcompartments of mouse lung and characterize, by sodium dodecyl sulfate polyacrylamide gel electrophoresis, the proteins to which arylating metabolites are bound. Reactive metabolite binding was substantially higher in incubations of [3H]- naphthalene with distal bronchioles and isolated Clara cells than with explants of trachea or bronchus from the mouse. Likewise, binding was substantially higher in incubations of murine Clara cells than in identical incubations with mouse hepatocytes (nontarget cells) or rat trachea cells (nonsusceptible species). These data show a good correlation between cellular susceptibility to toxicity and the amount of reactive metabolite bound in vitro. Concentrations of adduct were highest in the medium and the nuclear/cell debris fraction (1000 x g pellet) of isolated Clara cells incubated with naphthalene; very small amounts of adduct were noted in pellets isolated at 20,000 or at 100,000 x g (mitochondrial and microsomal fractions) or in cytosol. These observations were consistent with the finding that adduct concentrations in bronchoalveolar lavage were substantially higher than in the lung at low doses of naphthalene and suggest that monitoring adducts in lavage may serve as a useful biomarker of exposure and effect. [3H]-Naphthalene metabolites were bound primarily to three proteins: relative molecular weight, 14 to 15 (major), 30 and 45 kD (minor), in mouse Clara cell incubations; binding in hepatocyte incubations was solely to a protein of 14 to 15 kD. The chromatographic characteristics of the 14-kD adduct differed substantially from those of rat surfactant protein B or a secretory protein elaborated by Clara cells with a M(r) of 10 to 12 kD. Reactive metabolite binding to proteins in both Clara cells and hepatocytes appears to be highly selective. These studies suggest that the amount of metabolite bound to the 14 to 15 kD protein may be an important determinant in cellular susceptibility to naphthalene and that the nature of the major protein targeted in murine Clara cells (susceptible) and hepatocytes (nonsusceptible) is similar.

Original languageEnglish (US)
Pages (from-to)881-889
Number of pages9
JournalJournal of Pharmacology and Experimental Therapeutics
Volume269
Issue number2
StatePublished - 1994

Fingerprint

Proteins
Hepatocytes
Lung
Trachea
naphthalene
Uteroglobin
Bronchioles
Therapeutic Irrigation
Bronchoalveolar Lavage
Bronchi
Surface-Active Agents
Sodium Dodecyl Sulfate
Cytosol
Cytochrome P-450 Enzyme System
Polyacrylamide Gel Electrophoresis
Carrier Proteins
Necrosis
Biomarkers
Molecular Weight

ASJC Scopus subject areas

  • Pharmacology

Cite this

Covalent interactions of reactive naphthalene metabolites with proteins. / Cho, M.; Chichester, C.; Morin, D.; Plopper, Charles; Buckpitt, Alan R.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 269, No. 2, 1994, p. 881-889.

Research output: Contribution to journalArticle

@article{87730736e3d9400689f69955a26957ea,
title = "Covalent interactions of reactive naphthalene metabolites with proteins",
abstract = "Naphthalene produces selective necrosis of Clara cells in the mouse but not in the rat. The pulmonary toxicity depends on cytochrome P450-mediated metabolism; however, the selective pulmonary toxicity of naphthalene in the mouse does not correspond to tissue-selective covalent binding of reactive naphthalene metabolites in vivo. These studies compare reactive metabolite binding in target and nontarget cells and in various subcompartments of mouse lung and characterize, by sodium dodecyl sulfate polyacrylamide gel electrophoresis, the proteins to which arylating metabolites are bound. Reactive metabolite binding was substantially higher in incubations of [3H]- naphthalene with distal bronchioles and isolated Clara cells than with explants of trachea or bronchus from the mouse. Likewise, binding was substantially higher in incubations of murine Clara cells than in identical incubations with mouse hepatocytes (nontarget cells) or rat trachea cells (nonsusceptible species). These data show a good correlation between cellular susceptibility to toxicity and the amount of reactive metabolite bound in vitro. Concentrations of adduct were highest in the medium and the nuclear/cell debris fraction (1000 x g pellet) of isolated Clara cells incubated with naphthalene; very small amounts of adduct were noted in pellets isolated at 20,000 or at 100,000 x g (mitochondrial and microsomal fractions) or in cytosol. These observations were consistent with the finding that adduct concentrations in bronchoalveolar lavage were substantially higher than in the lung at low doses of naphthalene and suggest that monitoring adducts in lavage may serve as a useful biomarker of exposure and effect. [3H]-Naphthalene metabolites were bound primarily to three proteins: relative molecular weight, 14 to 15 (major), 30 and 45 kD (minor), in mouse Clara cell incubations; binding in hepatocyte incubations was solely to a protein of 14 to 15 kD. The chromatographic characteristics of the 14-kD adduct differed substantially from those of rat surfactant protein B or a secretory protein elaborated by Clara cells with a M(r) of 10 to 12 kD. Reactive metabolite binding to proteins in both Clara cells and hepatocytes appears to be highly selective. These studies suggest that the amount of metabolite bound to the 14 to 15 kD protein may be an important determinant in cellular susceptibility to naphthalene and that the nature of the major protein targeted in murine Clara cells (susceptible) and hepatocytes (nonsusceptible) is similar.",
author = "M. Cho and C. Chichester and D. Morin and Charles Plopper and Buckpitt, {Alan R}",
year = "1994",
language = "English (US)",
volume = "269",
pages = "881--889",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Covalent interactions of reactive naphthalene metabolites with proteins

AU - Cho, M.

AU - Chichester, C.

AU - Morin, D.

AU - Plopper, Charles

AU - Buckpitt, Alan R

PY - 1994

Y1 - 1994

N2 - Naphthalene produces selective necrosis of Clara cells in the mouse but not in the rat. The pulmonary toxicity depends on cytochrome P450-mediated metabolism; however, the selective pulmonary toxicity of naphthalene in the mouse does not correspond to tissue-selective covalent binding of reactive naphthalene metabolites in vivo. These studies compare reactive metabolite binding in target and nontarget cells and in various subcompartments of mouse lung and characterize, by sodium dodecyl sulfate polyacrylamide gel electrophoresis, the proteins to which arylating metabolites are bound. Reactive metabolite binding was substantially higher in incubations of [3H]- naphthalene with distal bronchioles and isolated Clara cells than with explants of trachea or bronchus from the mouse. Likewise, binding was substantially higher in incubations of murine Clara cells than in identical incubations with mouse hepatocytes (nontarget cells) or rat trachea cells (nonsusceptible species). These data show a good correlation between cellular susceptibility to toxicity and the amount of reactive metabolite bound in vitro. Concentrations of adduct were highest in the medium and the nuclear/cell debris fraction (1000 x g pellet) of isolated Clara cells incubated with naphthalene; very small amounts of adduct were noted in pellets isolated at 20,000 or at 100,000 x g (mitochondrial and microsomal fractions) or in cytosol. These observations were consistent with the finding that adduct concentrations in bronchoalveolar lavage were substantially higher than in the lung at low doses of naphthalene and suggest that monitoring adducts in lavage may serve as a useful biomarker of exposure and effect. [3H]-Naphthalene metabolites were bound primarily to three proteins: relative molecular weight, 14 to 15 (major), 30 and 45 kD (minor), in mouse Clara cell incubations; binding in hepatocyte incubations was solely to a protein of 14 to 15 kD. The chromatographic characteristics of the 14-kD adduct differed substantially from those of rat surfactant protein B or a secretory protein elaborated by Clara cells with a M(r) of 10 to 12 kD. Reactive metabolite binding to proteins in both Clara cells and hepatocytes appears to be highly selective. These studies suggest that the amount of metabolite bound to the 14 to 15 kD protein may be an important determinant in cellular susceptibility to naphthalene and that the nature of the major protein targeted in murine Clara cells (susceptible) and hepatocytes (nonsusceptible) is similar.

AB - Naphthalene produces selective necrosis of Clara cells in the mouse but not in the rat. The pulmonary toxicity depends on cytochrome P450-mediated metabolism; however, the selective pulmonary toxicity of naphthalene in the mouse does not correspond to tissue-selective covalent binding of reactive naphthalene metabolites in vivo. These studies compare reactive metabolite binding in target and nontarget cells and in various subcompartments of mouse lung and characterize, by sodium dodecyl sulfate polyacrylamide gel electrophoresis, the proteins to which arylating metabolites are bound. Reactive metabolite binding was substantially higher in incubations of [3H]- naphthalene with distal bronchioles and isolated Clara cells than with explants of trachea or bronchus from the mouse. Likewise, binding was substantially higher in incubations of murine Clara cells than in identical incubations with mouse hepatocytes (nontarget cells) or rat trachea cells (nonsusceptible species). These data show a good correlation between cellular susceptibility to toxicity and the amount of reactive metabolite bound in vitro. Concentrations of adduct were highest in the medium and the nuclear/cell debris fraction (1000 x g pellet) of isolated Clara cells incubated with naphthalene; very small amounts of adduct were noted in pellets isolated at 20,000 or at 100,000 x g (mitochondrial and microsomal fractions) or in cytosol. These observations were consistent with the finding that adduct concentrations in bronchoalveolar lavage were substantially higher than in the lung at low doses of naphthalene and suggest that monitoring adducts in lavage may serve as a useful biomarker of exposure and effect. [3H]-Naphthalene metabolites were bound primarily to three proteins: relative molecular weight, 14 to 15 (major), 30 and 45 kD (minor), in mouse Clara cell incubations; binding in hepatocyte incubations was solely to a protein of 14 to 15 kD. The chromatographic characteristics of the 14-kD adduct differed substantially from those of rat surfactant protein B or a secretory protein elaborated by Clara cells with a M(r) of 10 to 12 kD. Reactive metabolite binding to proteins in both Clara cells and hepatocytes appears to be highly selective. These studies suggest that the amount of metabolite bound to the 14 to 15 kD protein may be an important determinant in cellular susceptibility to naphthalene and that the nature of the major protein targeted in murine Clara cells (susceptible) and hepatocytes (nonsusceptible) is similar.

UR - http://www.scopus.com/inward/record.url?scp=0028284756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028284756&partnerID=8YFLogxK

M3 - Article

VL - 269

SP - 881

EP - 889

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 2

ER -